An observational 6-month study analysing effects of romosozumab in Osteoporosis
Latest Information Update: 29 Apr 2021
At a glance
- Drugs Romosozumab (Primary)
- Indications Corticosteroid-induced osteoporosis; Osteoporosis
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 29 Apr 2021 New trial record
- 01 Apr 2021 Results published in the Osteoporosis International